LIANBIO |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3148 USD | +3.23% |
|
-3.05% | -92.96% |
| 06:57am | Geely's EV Unit Zeekr Targets Up to $367.5 Million From NYSE IPO | MT |
| 18/03 | LianBio(OTCPK:LIAN.Y) dropped from NASDAQ Composite Index | CI |
Chart calendar LianBio
1975fe5fc52cae0cfa87ef5b5cdc799.fgHC30-qVZ2_ZXj99P1fwOjAm6i0ssW7Dh_XLqBc1t0.IWT7tBzID8XFIzO3oIc5r6Xx-djEhZT0WGy8f-1o4rUHdYmNHssb0Y4zNQ~827da84797e005ce10c5087e190f3643
Upcoming events on LianBio
Past events on LianBio
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 28/08/2023 08:30 pm | European Society of Cardiology Congress |
| 15/08/2023 01:35 am | Q2 2023 Earnings Release |
| 21/06/2023 05:30 pm | Annual General Meeting |
| 15/06/2023 10:30 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 09/06/2023 02:00 am | Jefferies Global Healthcare Conference - Fireside Chat |
| 12/05/2023 01:45 am | Q1 2023 Earnings Release |
| 01/05/2023 05:30 pm | Business Update Call |
| 27/03/2023 06:06 pm | Q4 2022 Earnings Release |
| 17/11/2022 02:45 am | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 16/11/2022 04:25 pm | Jefferies London Healthcare Conference |
| 16/11/2022 04:18 am | BioCentury-BayHelix East-West Biopharma Summit |
| 15/11/2022 10:30 pm | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 15/11/2022 06:30 am | Goldman Sachs Asia Pacific Healthcare Forum - Panel |
| 11/11/2022 02:35 am | Q3 2022 Earnings Release |
| 12/08/2022 01:35 am | Interim 2022 Earnings Release |
| 16/06/2022 03:10 am | Goldman Sachs Global Healthcare Conference |
| 10/06/2022 08:30 pm | Jefferies Healthcare Conference |
| 12/05/2022 06:50 pm | Bank of America Healthcare Conference |
| 12/05/2022 05:30 pm | Q1 2022 Earnings Release |
Past dividends on LianBio
| 15/03/2024 | 4.75 USD |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 6,67 - |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -195 -209 6.83% | -124 -123 -1.26% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -196 -206 5.09% | -125 -126 0.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -196 -198 1.16% | -111 -114 2.56% |
|
Net income Million USD | Released Forecast Spread | -140 | -196 -204 3.94% | -110 -118 6.3% |
|
EPS USD | Released Forecast Spread | -67,7 | -5,71 -4,51 -26.7% | -1,02 -1,23 17.3% |
| Announcement Date | 09/08/21 | 30/03/22 | 27/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 6,67 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -13,3 -39,1 66.02% | -21,8 -35,8 39.05% | -28,1 -23,0 -22.37% | -43,0 -29,0 -48.29% | -23,5 -44,3 47.06% | -28,9 -5,01 -477.41% | -25,6 -31,7 18.97% | -24,7 -32,0 22.77% | -26,0 -36,1 27.98% |
|
EBIT Million USD | Released Forecast Spread | -13,5 -22,2 39.1% | -22,0 -32,6 32.46% | -60,5 -24,4 -148.4% | -43,1 -29,1 -48.06% | -24,5 -42,4 42.14% | -29,2 -29,6 1.34% | -26,0 -29,9 13.28% | -25,0 -32,1 22.03% | -26,3 -36,4 27.71% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,5 -20,0 32.47% | -22,2 -24,6 9.52% | -60,6 -23,6 -156.47% | -42,4 -30,3 -39.96% | -21,9 -44,4 50.72% | -18,6 -20,3 8.45% | -23,6 -32,0 26.25% | -21,4 -25,6 16.28% | -23,5 -24,3 3.49% |
|
Net income Million USD | Released Forecast Spread | -13,1 -30,7 57.29% | -21,2 -30,3 29.95% | -61,6 -22,0 -179.99% | -42,4 -30,6 -38.66% | -21,9 -45,0 51.33% | -18,3 -22,9 20.24% | -24,0 -29,0 17.11% | -21,6 -28,9 25.27% | -24,0 -29,5 18.6% |
|
EPS USD | Released Forecast Spread | -0,63 -0,35 -81.73% | -0,28 -0,33 15.15% | -3,01 -0,26 -1057.69% | -0,39 -0,28 -37.65% | -0,20 -0,42 52% | -0,17 -0,22 21.54% | -0,22 -0,27 19.51% | -0,20 -0,27 25.93% | -0,22 -0,29 22.81% |
| Announcement Date | 09/12/21 | 30/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 14/08/23 | 13/11/23 |
| Today 04:30 pm | RHYTHM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | MADRIGAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 01:31 am | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | RAPT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | 89BIO, INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | DYNAVAX TECHNOLOGIES CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | BEIGENE, LTD.: Q1 2024 Earnings Release |
| 09/05/2024 01:30 am | MANNKIND CORPORATION: Q1 2024 Earnings Release |
Past sector events for LianBio
| Today | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| Today | Y-MABS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release (Projected) |
| Today | PHILOGEN S.P.A.: Q1 2024 Earnings Release |
| 07/05/2024 01:35 am | ORIC PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:31 am | ROCKET PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:31 am | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 06/05/2024 05:30 pm | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 05:30 pm | LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LIANY Stock
- Calendar LianBio